https://neximmune.com/ 2026-05-27T06:20:53Z https://neximmune.com/author/rajeshl/ 2026-05-27T06:20:54Z https://neximmune.com/author/schwaguy/ 2026-05-27T06:20:54Z https://neximmune.com/careers/ 2026-05-27T06:20:53Z https://neximmune.com/contact/ 2026-05-27T06:20:53Z https://neximmune.com/cookies/ 2026-05-27T06:20:53Z https://neximmune.com/newsroom/ 2026-05-27T06:20:53Z https://neximmune.com/newsroom/media-inquires/ 2026-05-27T06:20:55Z https://neximmune.com/newsroom/media-inquiries/ 2026-05-27T06:20:53Z https://neximmune.com/our-company/ 2026-05-27T06:20:53Z https://neximmune.com/our-company/autoimmune-and-infectious-diseases-sab/ 2026-05-27T06:20:53Z https://neximmune.com/our-company/bod/ 2026-05-27T06:20:53Z https://neximmune.com/our-company/leadership/ 2026-05-27T06:20:53Z https://neximmune.com/our-company/scientific-advisory-board/ 2026-05-27T06:20:53Z https://neximmune.com/our-pipeline/nexi-001-program/ 2026-05-27T12:00:00Z https://neximmune.com/our-pipeline/ 2026-05-27T06:20:53Z https://neximmune.com/our-technology/ 2026-05-27T06:20:54Z https://neximmune.com/our-technology/abstracts-and-publications/ 2026-05-27T06:20:53Z https://neximmune.com/our-technology/aim-np-adoptive-cellular-therapy-act/ 2026-05-27T06:20:53Z https://neximmune.com/our-technology/aim-np-direct-injection/ 2026-05-27T06:20:53Z https://neximmune.com/our-technology/aim-nt-platform/ 2026-05-27T06:20:55Z https://neximmune.com/privacy/ 2026-05-27T06:20:53Z https://neximmune.com/terms-of-use/ 2026-05-27T06:20:53Z